Patents Assigned to Roche Sequencing Solutions, Inc.
  • Patent number: 12378596
    Abstract: The invention is a method of single cell transcriptome analysis. The method comprises detecting multiple transcripts in each individual cell of the plurality of cells by barcoding the transcripts with a cell-specific compound barcode formed using a DNA polymerase and a terminal transferase, optionally in a single enzyme such as a reverse transcriptase.
    Type: Grant
    Filed: December 3, 2020
    Date of Patent: August 5, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Martin Ranik, Florian Rubelt, Sedide Ozturk
  • Patent number: 12378604
    Abstract: Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from V149K, E287R, H35G, T109K, P151K, K147N, E111N, M113A, or combinations thereof in the mature, wild-type alpha-hemolysin amino acid sequence. The ?-hemolysin variants may also include a substitution at H144A and/or a series of glycine residues spanning residues 127 to 131 of the mature, wild-type alpha hemolysin. Also provided are nanopore assemblies including the alpha-hemolysin variants, the assembly having a decreased time-to-thread. The decreased time-to-thread, for example, increases DNA sequencing efficiency and accuracy.
    Type: Grant
    Filed: February 25, 2021
    Date of Patent: August 5, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Timothy K. Craig, Mark R. Ambroso, Corissa J. Harris, Matthew M. Dipietro, Yaozhong Zou, Marshall W. Porter
  • Patent number: 12371745
    Abstract: A nanopore cell includes a conductive layer. The nanopore cell further includes a titanium nitride (TiN) working electrode disposed above the conductive layer. The nanopore cell further includes insulating walls disposed above the TiN working electrode, wherein the insulating walls and the TiN working electrode form a well into which an electrolyte may be contained. In some embodiments, the TiN working electrode comprises a spongy and porous TiN working electrode that is deposited by a deposition technique with conditions tuned to deposit sparsely-spaced TiN columnar structures or columns of TiN crystals above the conductive layer.
    Type: Grant
    Filed: August 23, 2021
    Date of Patent: July 29, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: John Foster, Jason Komadina
  • Patent number: 12372511
    Abstract: A method of forming a plurality of lipid bilayers over an array of cells in a nanopore based sequencing chip is disclosed. Each of the cells comprises a well. A first salt buffer solution with a first osmolarity is flowed over a cell in the nanopore based sequencing chip to substantially fill a well in the cell with the first salt buffer solution. A lipid and solvent mixture is flowed over the cell to deposit a lipid membrane over the well that encloses the first salt buffer solution in the well. A second salt buffer solution with a second osmolarity is flowed above the well to reduce the thickness of the lipid membrane, wherein the second osmolarity is a lower osmolarity than the first osmolarity such that an osmotic imbalance is created between a first volume inside the well and a second volume outside the well.
    Type: Grant
    Filed: May 8, 2024
    Date of Patent: July 29, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Geoffrey Barrall, Licheng Niu, Pirooz Parvarandeh
  • Publication number: 20250236633
    Abstract: The present disclosure relates to a process for the regiochemically and enantiomerically controlled synthesis of phosphoramidite-containing monomers, and to intermediate products of this process. In some embodiments, the phosphoramidite-containing monomers or their precursors are regioisomerically and/or enantiomerically pure and may be polymerized into polymers or copolymers.
    Type: Application
    Filed: September 25, 2024
    Publication date: July 24, 2025
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Brent Banasik, Julian Andres Diaz Corral, Aaron Jacobs, Lukas Jud, Hannes Kuchelmeister, Melud Nbavi, Toni Pfaffeneder, Sona Simonyiova, John C. Tabone, Wilma Thuer
  • Patent number: 12365941
    Abstract: A method of detecting a lipid bilayer formed in a cell of a nanopore based sequencing chip is disclosed. An integrating capacitor is coupled with a lipid membrane, wherein the lipid membrane is between a working electrode and a counter electrode. An alternating current (AC) voltage is applied to the counter electrode. A voltage across the integrating capacitor is periodically sampled by an analog-to-digital converter (ADC). A change in the sampled voltage across the integrating capacitor in response to a change in the AC voltage is determined. Whether the lipid membrane comprises a lipid bilayer is detected based on the determined change in the sampled voltage across the integrating capacitor in response to the change in the AC voltage.
    Type: Grant
    Filed: February 5, 2024
    Date of Patent: July 22, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Kevin Aliado, Roger J. A. Chen, Jing Luo, William Nielsen, Kyle Umeda, Ashraf Wahba
  • Patent number: 12350891
    Abstract: Techniques for forming a nanopore in a lipid bilayer are described herein. In one example, an agitation stimulus level such as an electrical agitation stimulus is applied to a lipid bilayer wherein the agitation stimulus level tends to facilitate the formation of nanopores in the lipid bilayer. In some embodiments, a change in an electrical property of the lipid bilayer resulting from the formation of the nanopore in the lipid bilayer is detected, and a nanopore has formed in the lipid bilayer is determined based on the detected change in the lipid bilayer electrical property.
    Type: Grant
    Filed: December 19, 2023
    Date of Patent: July 8, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Roger J. A. Chen, Randy Davis
  • Patent number: 12351875
    Abstract: Described herein are methods, systems, and apparatuses for detecting significantly mutated genes/pathways in a cancer cohort. A driver gene detection technique taking into account the heterogeneous mutational context in a cancer cohort is disclosed. A statistical model of a gene-specific mutation rate distribution (e.g., using an optimized gene specific mean estimation and/or a gene-specific dispersion estimation) is used to model a sample/gene-specific background mutation rate. The statistical model may then be used to detect gene/pathway enrichment and distinguish tumor suppressors and oncogenes based on the spatial distribution of non-silent mutations, loss-of-function mutations, and/or gain-of-function mutations.
    Type: Grant
    Filed: April 14, 2017
    Date of Patent: July 8, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Yao Fu, Aparna Chhibber, Marghoob Mohiyuddin, Li Tai Fang, Hugo Y. K. Lam
  • Patent number: 12311357
    Abstract: The present disclosure generally relates to devices and methods for effecting epitachophoresis. Epitachophoresis may be used to effect sample analysis, such as by selective separation, detection, extraction, and/or pre-concentration of target analytes such as, for example, DNA, RNA, and/or other biological molecules. Said target analytes may be collected following epitachophoresis and used for desired downstream applications and further analysis.
    Type: Grant
    Filed: May 15, 2023
    Date of Patent: May 27, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Yann Astier, Jan Berka, Ulrich Schlecht, Frantisek Foret, Vladimira Datinska, Ivona Voracova
  • Patent number: 12313584
    Abstract: Molecules may be analyzed (e.g., sequencing of nucleic acid molecules) by tunneling recognition at a tunneling junction. Embodiments of the present invention may allow detecting individual nucleotides and the sequencing of a nucleic acid molecule using a tunneling junction. By labeling a specific 5 nucleotide with a moiety, tunneling junctions may generate a signal with a suitable signal-to-noise ratio. An electric field may be applied to move the nucleic acid molecule and the moiety close to the tunneling junction so that a current may travel through the moiety. Because a single nucleotide can be detected with a signal with a suitable signal-to-noise ratio resulting from the tunneling current passing through 10 the moiety, embodiments of the present invention may allow for fast detection of nucleotides using a tunneling current.
    Type: Grant
    Filed: June 19, 2019
    Date of Patent: May 27, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Yann Astier, Zsolt Majzik, Flint Mitchell, Juraj Topolancik
  • Patent number: 12313588
    Abstract: A nanopore based sequencing system includes a plurality of nanopore sensors. Each nanopore sensor has a portion for receiving a fluid. The nanopore based sequencing system includes a fluid chamber configured to guide the fluid over the plurality of nanopore sensors and an inlet configured to deliver the fluid into the fluid chamber. At least a portion of the fluid chamber is made of a material that has been molded around at least a portion of an electrode.
    Type: Grant
    Filed: May 12, 2023
    Date of Patent: May 27, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Edward Liu, Kenneth M. Stothers, Markus Wallgren, Janusz B. Wojtowicz, Robert A. Yuan
  • Patent number: 12298294
    Abstract: Techniques for increasing the density and the number of cells on a nanopore sensor chip are disclosed. Two or more cells of the nanopore sensor chip share some analog components (e.g., an integration capacitor and/or a read-out transistor) through one or more digital relays. Under the control of various control signals during a sampling period of the sensor chip, the two or more cells are connected one at time to the shared analog components and are measured one at a time using the shared analog components. In this way, the average size of the cells on the sensor chip is reduced to increase the cell density without affecting the analog measurement performance of the cells.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: May 13, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventor: J. William Maney, Jr.
  • Patent number: 12297491
    Abstract: The present invention is a method and compositions for primer extension target enrichment of nucleic acids and improvements thereto including simultaneously enriching for RNA and DNA and optionally sequencing the enriched products.
    Type: Grant
    Filed: October 12, 2022
    Date of Patent: May 13, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Brian Christopher Godwin, Sedide Ozturk
  • Patent number: 12298272
    Abstract: A method of analyzing a molecule in a nanopore is disclosed. A voltage is applied across a nanopore that is inserted in a membrane by coupling the nanopore to a voltage source. The nanopore is decoupled from the voltage source. After the decoupling, a rate of decay of the voltage across the nanopore is determined. A molecule in the nanopore is distinguished from other possible molecules based on the determined rate of decay of the voltage across the nanopore.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: May 13, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Roger J. A. Chen, Hui Tian, J. William Maney, Jr.
  • Patent number: 12297497
    Abstract: This disclosure provides a biochip comprising a plurality of wells. The biochip includes a membrane that is disposed in or adjacent to an individual well of the plurality of wells. The membrane comprises a nanopore, and the individual well comprises an electrode that detects a signal upon ionic flow through the pore in response to a species passing through or adjacent to the nanopore. The electrode can be a non-sacrificial electrode. A lipid bilayer can be formed over the plurality of wells using a bubble.
    Type: Grant
    Filed: June 19, 2023
    Date of Patent: May 13, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Randall W. Davis, Edward Shian Liu, Eric Takeshi Harada, Anne Aguirre, Andrew Trans, James Pollard, Cynthia Cech
  • Publication number: 20250146065
    Abstract: A method of forming a plurality of lipid bilayers over an array of cells in a nanopore based sequencing chip is disclosed. Each of the cells comprises a well. A salt buffer solution is flowed over the array of cells in the nanopore based sequencing chip to substantially fill the wells in the cells with the salt buffer solution. A lipid and solvent mixture is flowed over the array of cells to deposit the lipid and solvent mixture over at least some of the wells in the cells. A first portion of the cells, each having a lipid bilayer over its well, is detected. A second portion of the cells, each having a lipid membrane but not a lipid bilayer over its well, is detected. An electrical lipid-thinning stimulus is selectively applied to the second portion of the cells but not to the first portion of the cells.
    Type: Application
    Filed: November 18, 2024
    Publication date: May 8, 2025
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Kevin Aliado, Roger J.A. Chen, Jing Luo, J. William Maney, JR., William Nielsen, Kyle Umeda, Ashraf Wahba
  • Publication number: 20250144617
    Abstract: Techniques for replacing nanopores within a nanopore based sequencing chip are provided. A first electrolyte solution is added to the external reservoir of the sequencing chip, introducing an osmotic imbalance between the reservoir and the well chamber located on the opposite side of a lipid bilayer membrane. The osmotic imbalance causes the membrane to change shape, and a nanopore within the membrane to be ejected. A second electrolyte solution is then added to the external reservoir to provide replacement nanopores and to restore the membrane shape. The replacement nanopores can be inserted into the membrane, effectively replacing the initial pore without causing the destruction of the membrane.
    Type: Application
    Filed: January 8, 2025
    Publication date: May 8, 2025
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Geoffrey Barrall, Takeshi Harada, Jason Komadina, Pirooz Parvarandeh, Charlotte Yang
  • Publication number: 20250123264
    Abstract: A method of forming a nanopore in a lipid bilayer is disclosed. A nanopore forming solution is deposited over a lipid bilayer. The nanopore forming solution has a concentration level and a corresponding activity level of pore molecules such that nanopores are substantially not formed un-stimulated in the lipid bilayer. Formation of a nanopore in the lipid bilayer is initiated by applying an agitation stimulus level to the lipid bilayer. In some embodiments, the concentration level and the corresponding activity level of pore molecules are at levels such that less than 30 percent of a plurality of available lipid bilayers have nanopores formed un-stimulated therein.
    Type: Application
    Filed: October 31, 2024
    Publication date: April 17, 2025
    Applicant: Roche Sequencing Solutions, Inc.
    Inventors: Roger J.A. Chen, Randall Davis
  • Patent number: 12270125
    Abstract: The present disclosure provides a method of preparing a library of nucleic acids having modular end sequences. The method includes combining a pool of different modular nucleic acid tags with a nucleic acid sample, the nucleic acid sample including a plurality of double-stranded target nucleic acids. The method further includes joining the ends of each of the double-stranded target nucleic acids to tags selected from the pool of different modular nucleic acid tags to form a plurality of doubly-tagged target nucleic acids, amplifying each of the doubly-tagged target nucleic acids, thereby preparing a library of nucleic acids having modular end sequences, and detecting the library of amplified nucleic acids having modular end sequences.
    Type: Grant
    Filed: September 19, 2019
    Date of Patent: April 8, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventor: Alexandra Hui Wang
  • Patent number: 12270070
    Abstract: The invention is a novel method of generating a library of circular single stranded nucleic acid molecules by utilizing circular capture molecules. The method is not limited by size of target nucleic acid molecules and can potentially accommodate very long molecules. The method finds application in nucleic acid sequencing, e.g., nanopore sequencing where unlimited-length templates can be read.
    Type: Grant
    Filed: September 21, 2021
    Date of Patent: April 8, 2025
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Rui Chen, Toumy Guettouche, Aaron Richardson